Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Biogencell Ltd.
Sponsor

Biogencell Ltd.

16, Divrei Khayim, 4244916

About the sponsor

Biogencell Ltd. is focused on clinical research in peripheral arterial disease and critical limb ischemia, particularly in patients with advanced limb ischemia who remain symptomatic despite standard pharmacological management and control of cardiovascular risk factors.

  • Peripheral arterial disease (PAD)
  • Critical limb ischemia (CLI)
  • Chronic limb-threatening ischemia (CLTI)

The sponsor’s research interest includes patients with persistent microvascular disease after prior revascularization and those without remaining options for further revascularization treatment.

About Specializations

Biogencell Ltd. runs clinical trials in conditions such as Peripheral arterial occlusive disease, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Peripheral arterial occlusive disease

Not recruiting

Study on BGC101 for Treating Peripheral Arterial Disease with Critical Limb Ischemia in Patients Not Responding to Standard Treatments

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Blood-Derived Endothelial Progenitor Cells, Haematopoietic Stem/Progenitor Cells, Activated Dendritic Cells And T Helper Cells
  • Sponsor:Biogencell Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.